Multidisciplinary Management of Stage III and IVa Thymoma

Overview

This webinar presents a multidisciplinary tumor board format to explore the management of complex Stage III and IVa thymomas. It will address current gaps by offering expert consensus and practical take-home points based on available literature and clinical experience.

CME Accredited

Learning Objectives:
ACCME:

Be comfortable to present a patient with stage III or IVa thymoma in a multidisciplinary tumor board.
Determine the optimal treatment regimen for Stage III and IVa thymoma.
Discuss future areas of study in the management of Stage III and IVa thymoma.

The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:

Be comfortable to present a patient with stage III or IVa thymoma in a multidisciplinary tumor board.
Determine the optimal treatment regimen for Stage III and IVa thymoma.
Discuss future areas of study in the management of Stage III and IVa thymoma.

ACCME:

The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.